首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Twelve Weeks of Pioglitazone Therapy Significantly Attenuates Dysmetabolism and Reduces Inflammation in Continuous Ambulatory Peritoneal Dialysis Patients—a Randomized Crossover Trial

【24h】

Twelve Weeks of Pioglitazone Therapy Significantly Attenuates Dysmetabolism and Reduces Inflammation in Continuous Ambulatory Peritoneal Dialysis Patients—a Randomized Crossover Trial

机译：连续12周的吡格列酮疗法可显着减轻持续性非卧床腹膜透析患者的代谢异常并减少炎症-一项随机交叉试验

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis》 |2012年第5期|共页
作者
Chuan-ming Hao; Huai-zhou You; Jing Tian; Qiong-hong Xie; Shan-yan Lin; Tong-ying Zhu; Yun Li;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients-a randomized crossover trial [J] . LiY., XieQ., YouH., Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis . 2012,第5期

机译：吡格列酮治疗十二周可显着减轻持续性非卧床腹膜透析患者的代谢异常并减少炎症-一项随机交叉试验
2. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? [J] . Cueto Manzano AM, Rojas Campos E, Martinez Ramirez HR, Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis . 2006,第3期

机译：夜间间歇性腹膜透析可减少持续性非卧床腹膜透析中高腹膜通透性患者的炎症标志物吗？
3. Anti-Inflammatory interventions in end-stage kidney disease: A randomized, double-blinded, controlled and crossover clinical trial on the use of pravastatin in continuous ambulatory peritoneal dialysis [J] . Cueto-ManzanoA.M., ángel-Zú?igaJ.R., Ornelas-CarrilloG., Archives of medical research . 2013,第8期

机译：终末期肾脏疾病的抗炎干预措施：普伐他汀用于连续非卧床腹膜透析的随机，双盲，对照和交叉临床试验
4. Residual Renal Function in Children Treated with Continuous Ambulatory Peritoneal Dialysis or Automated Peritoneal Dialysis-A Preliminary Study [C] . Maria Roszkowska-Blaim, Piotr Skrzypczyk, Dorota Drozdz, Conference on Peritoneal Dialysis . 2009

机译：用连续的动态腹膜透析或自动腹膜透析治疗儿童残留肾功能 - 初步研究
5. The Effectiveness of an Evidence-based Continuous Ambulatory Peritoneal Dialysis (CAPD) Retraining Program to Reduce Peritonitis among Incident CAPD Patients [D] . Leung, Wai Yin. 2019

机译：基于证据的连续动态腹膜透析（CAPD）再培训计划的有效性降低了事件CAPD患者的腹膜炎
6. Twelve Weeks of Pioglitazone Therapy Significantly Attenuates Dysmetabolism and Reduces Inflammation in Continuous Ambulatory Peritoneal Dialysis Patients—a Randomized Crossover Trial [O] . Yun Li, Qiong-hong Xie, Huai-zhou You, 2012

机译：连续12周的吡格列酮治疗可显着减轻持续性非卧床腹膜透析患者的代谢不良和炎症减少这是一项随机交叉试验。
7. Efficacy of triple diuretic treatment in continuous ambulatory peritoneal dialysis patients: A randomized controlled trial [O] . Raweewan Witoon, Somchai Yongsiri, Prapan Buranaburidej, 2019

机译：三重利尿处理在连续动态腹膜透析患者中的功效：随机对照试验
8. Investigation of the Risks and Hazards with Devices Associated with Peritoneal Dialysis (Including Intermittent Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis) and Sorbent Regenerated Dialysate Delivery Systems [R] . Ward, R. A. 1982

机译：腹膜透析（包括间歇性腹膜透析和持续性非卧床腹膜透析）和吸附剂再生透析液输送系统相关设备的风险和危害调查

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号